Clinical characteristics of ovarian mucinous adenocarcinoma

Li Yi,Zhang Yunna,Ma Yu
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2012.02.014
2012-01-01
Abstract:Objective:To summarize the clinical characteristics of primary mucinous ovarian carcinoma.Methods:A retrospective study was performed on 24 mucinous and 108 non-mucinous ovarian carcinoma patients including age,FIGO stage,residual disease,response rate to paclitaxel/platinum chemotherapy.The survival time was compared between two groups and the prognostic factors were analyzed.Results:The age was similar between two groups,while the mucinous carcinoma group had less advanced FIGO stage(P=0.001) and lower tumor grading(P=0.000).Although the overall rate of optimal debulking surgery was higher in mucinous group(P=0.020),there was no difference in advanced patients(P=0.453).Response rate to platinum-based chemotherapy was 63.2% and 85.2%,respectively(P=0.212).There seemed no relation with FIGO stage and residual disease in platium-resistant mucinous carcinoma patients,the response rate dramatically reduced to 40% in recurrent patients.The median progression-free survival(PFS) of all stages of mucinous and non-mucinous group was 22 months and 17 months(P=0.393),the median overall survival(OS) was 22 months and 37.5 months(P=0.670),respectively.While the median PFS of early stage patients was 37.5 months and 44 months(P=0.304),the median OS was 49 months and 45 months(P=0.621),respectively.The median PFS was worse in stage Ⅲ/Ⅳ mucinous carcinoma patients after optimal debulking surgery(mucinous vs non-mucinous:12 vs 27 months,P=0.003),and worse OS(mucinous vs non-mucinous:18 vs 45 months,P=0.044);but there was no difference between two groups with stage Ⅲ/Ⅳ after sub-optimal debulking surgery.Cox regression analysis showed the mucinous histology,FIGO stage and residual disease were prognostic factors for PFS,only residual tumor size was the progostic factor for OS.Conclusions:Mucinous ovarian carcinoam is an unique type in epithelial carcinoma.The prognosis was poor in advanced mucinous carcinoma patients.Cytoreductive surgery is still the first line therapy.Platinum-based chemotherapy resistance may be associated with poor prognosis,therefore new effective chemotherapy regimen should be developed.
What problem does this paper attempt to address?